News
-
-
COMMUNIQUÉ DE PRESSE
PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE
Defence Therapeutics Inc. successfully completes pre-clinical trial using its ARM-002 anti-cancer vaccine against pancreatic cancer, showing therapeutic effectiveness and potential benefits -
COMMUNIQUÉ DE PRESSE
CBo Territoria governance evolution
The Board of Directors of CBo Territoria announces governance changes, including the resignation of Mr. Eric Wuillai as Chairman. Géraldine Neyret Gleizes to take on the role of Chairman and CEO. Financial calendar includes the Annual Shareholders' Meeting on May 2, 2024 -
-
COMMUNIQUÉ DE PRESSE
Interim report for the first quarter of 2024 – Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms
Ørsted A/S releases interim report for Q1 2024, operating profit on target with offshore site earnings up 18%. Progress with Sunrise Wind project and completion of 2 offshore wind farms -
-
-
-
-
